BENSLEY

AGL Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Has Filed a Securities Fraud Class Action Lawsuit Against agilon health, inc. on Their Behalf (AGL)

Retrieved on: 
Sunday, April 21, 2024

RADNOR, Pa., April 21, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ( NYSE: AGL ) (“agilon” or the “Company”).

Key Points: 
  • RADNOR, Pa., April 21, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ( NYSE: AGL ) (“agilon” or the “Company”).
  • The filing of the Hope Action does not change the May 20, 2024, lead plaintiff deadline.
  • Kessler Topaz Meltzer & Check, LLP encourages agilon investors who have suffered significant losses to contact the firm directly to acquire more information.
  • A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation.

AGL CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds agilon health, inc. Shareholders of Securities Fraud Class Action Lawsuit

Retrieved on: 
Sunday, April 14, 2024

RADNOR, Pa., April 14, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ( NYSE: AGL ) (“agilon” or the “Company”).

Key Points: 
  • RADNOR, Pa., April 14, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ( NYSE: AGL ) (“agilon” or the “Company”).
  • The filing of the Hope Action does not change the May 20, 2024, lead plaintiff deadline.
  • Kessler Topaz Meltzer & Check, LLP encourages agilon investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel.

agilon health, inc. Investors: May 20, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP

Retrieved on: 
Saturday, April 27, 2024

The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ( NYSE: AGL ) (“agilon” or the “Company”).

Key Points: 
  • The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ( NYSE: AGL ) (“agilon” or the “Company”).
  • The filing of the Hope Action does not change the May 20, 2024, lead plaintiff deadline.
  • Kessler Topaz Meltzer & Check, LLP encourages agilon investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel.

(AGL) CLASS ACTION ANNOUNCMENT: Kessler Topaz Meltzer & Check, LLP Notifies agilon health, inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit

Retrieved on: 
Wednesday, April 10, 2024

RADNOR, Pa., April 10, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ( NYSE: AGL ) (“agilon” or the “Company”).

Key Points: 
  • RADNOR, Pa., April 10, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ( NYSE: AGL ) (“agilon” or the “Company”).
  • The filing of the Hope Action does not change the May 20, 2024, lead plaintiff deadline.
  • One of agilon’s key financial metrics is “medical margin,” which the Company defines as medical services revenue less medical services expenses.
  • Kessler Topaz Meltzer & Check, LLP encourages agilon investors who have suffered significant losses to contact the firm directly to acquire more information.

CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Has Filed A Securities Fraud Class Action Lawsuit Against agilon health, inc.

Retrieved on: 
Saturday, April 6, 2024

RADNOR, Pa., April 06, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ( NYSE: AGL ) (“agilon” or the “Company”).

Key Points: 
  • RADNOR, Pa., April 06, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ( NYSE: AGL ) (“agilon” or the “Company”).
  • The filing of the Hope Action does not change the May 20, 2024, lead plaintiff deadline.
  • Kessler Topaz Meltzer & Check, LLP encourages agilon investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel.

Investor Alert (NYSE: AGL): Kessler Topaz Meltzer & Check, LLP Files a Securities Fraud Class Action Lawsuit Against agilon health, inc. With Expanded Class Period and Encourages Investors With Substantial Losses to Contact the Firm

Retrieved on: 
Monday, March 25, 2024

Important Deadline Reminder: There is one related class action case pending against agilon in the United States District Court for the Western District of Texas.

Key Points: 
  • Important Deadline Reminder: There is one related class action case pending against agilon in the United States District Court for the Western District of Texas.
  • The filing of the Hope Action does not change the May 20, 2024, lead plaintiff deadline.
  • Kessler Topaz Meltzer & Check, LLP encourages agilon investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel.

Investor Alert (NYSE: AGL): Kessler Topaz Meltzer & Check, LLP Files a Securities Fraud Class Action Lawsuit Against agilon health, inc. With Expanded Class Period and Encourages Investors With Substantial Losses to Contact the Firm

Retrieved on: 
Monday, March 25, 2024

Important Deadline Reminder: There is one related class action case pending against agilon in the United States District Court for the Western District of Texas.

Key Points: 
  • Important Deadline Reminder: There is one related class action case pending against agilon in the United States District Court for the Western District of Texas.
  • The filing of the Hope Action does not change the May 20, 2024, lead plaintiff deadline.
  • Kessler Topaz Meltzer & Check, LLP encourages agilon investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel.

agilon health Announces Tim Bensley to Retire as CFO

Retrieved on: 
Friday, January 5, 2024

agilon health, Inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that Timothy Bensley has informed the company of his intent to retire from his position as Chief Financial Officer (CFO) during 2024, which agilon expects to take place within the next nine months.

Key Points: 
  • agilon health, Inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that Timothy Bensley has informed the company of his intent to retire from his position as Chief Financial Officer (CFO) during 2024, which agilon expects to take place within the next nine months.
  • The search for a new CFO has been initiated, and Bensley has agreed to remain as CFO through this process and serve in a consulting role through the transition.
  • “I want to thank Tim for his leadership over the past three years at agilon health, and for the impact he has had on our company, our physician partners, and the communities we serve,” said Steve Sell, chief executive officer, agilon health.
  • “Tim helped advance our finance function and was key in agilon’s transition to become a publicly traded company in 2021.